Top Markets
Coin of the day
Genenta Science S.p.A. Genenta Science S.p.A.

Genenta Science S.p.A.

GNTA
Kedudukan dalam Saham #28059
Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused... Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused on pioneering hematopoietic stem cell gene therapies to combat solid tumors. Its primary therapeutic candidate, Temferon, is currently undergoing Phase 1/2a clinical evaluation. This innovative therapy is being developed to treat glioblastoma multiforme, specifically targeting patients whose tumors exhibit an unmethylated MGMT gene promoter. Beyond this, Genenta Science is exploring Temferon's potential application in various other solid tumor types, including locally advanced hepatocellular carcinoma and intra-hepatic cholangiocarcinoma. Established in 2014, the company maintains its headquarters in Milan, Italy.
Harga Saham
$1.51
Disegerakkan terakhir: 2026-07-31
Modal Pasaran
$28.82M
Perubahan (1 hari)
-0.33%
Perubahan (1 tahun)
-57.49%
Negara
IT
Perdagangan Genenta Science S.p.A. (GNTA)

Kategori

Sejarah harga saham bagi Genenta Science S.p.A. (GNTA)
Harga penutupan tertinggi: $1.55 pada 2026-07-01

Harga penutupan terendah: $11.33 pada 2021-12-01
Sejarah harga saham Genenta Science S.p.A. dari 2021 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 7.52%
2025 -68.48%
2024 -0.35%
2023 -6.83%
2022 -51.72%
2021 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$122.91 -13.46%
AU
$753.28 5.84%
CH